FEMY实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

Stats
今日成交量	62 179.00
平均成交量	717 382
市值	28.66M
EPS	$0 ( 2024-04-04 )
下一个收益日期	( $-0.220 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.390
ATR14	$0.00600 (0.46%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-12	Spector Richard D.	Buy	100 000	Stock Option (Right to Buy)
2024-02-12	Spector Richard D.	Buy	0
2024-02-01	Currie Daniel Scott	Buy	61 900	Stock Option (Right to Buy)
2024-02-01	Elefant Dov	Buy	84 000	Stock Option (Right to Buy)
2024-02-01	Thomas Christine E	Buy	32 600	Stock Option (Right to Buy)

INSIDER POWER
-78.97
Last 82 transactions
Buy: 6 908 475 \| Sell: 19 734 221

音量相关性

長: -0.10 (neutral)

短: -0.82 (strong negative)

Signal:(61.791) Neutral

Femasys Inc. 相关性

10 最正相关
POWL	0.929
VEON	0.922
ALRM	0.917
OCUL	0.917
IOVA	0.916
CLBT	0.915
TARA	0.91
PXLW	0.906
QRTEA	0.905
PEPG	0.905

10 最负相关
DCRC	-0.919
SGLB	-0.904
CYAN	-0.873
SSRM	-0.868
DSWL	-0.859
GIGM	-0.859
BLKB	-0.858
GRNA	-0.855
DSPC	-0.85
WTER	-0.846

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Femasys Inc. 相关性 - 货币/商品

0.75
( moderate )

0.41
( neutral )

0.00
( neutral )

0.16
( neutral )

-0.77
( moderate negative )

Femasys Inc. 财务报表

Annual	2023
营收:	$1.07M
毛利润:	$-216 084 (-20.16 %)
EPS:	$-0.930

FY	2023
营收:	$1.07M
毛利润:	$-216 084 (-20.16 %)
EPS:	$-0.930

FY	2022
营收:	$1.21M
毛利润:	$764 280 (63.36 %)
EPS:	$-0.970

FY	2021
营收:	$1.18M
毛利润:	$809 305 (68.60 %)
EPS:	$-0.831

Financial Reports:

No articles found.

Femasys Inc.

Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.

实时更新： Femasys Inc. [FEMY]

Upcoming Earnings Alert